Steven Crossan

Steve Crossan is the cofounder of Dayhoff Labs who’s mission is to reverse engineer the chemistry of life via its origins. He was a founding team member of AlphaFold at DeepMind and VP of AI at GSK. He has invested in and advised many AI bio companies including Relation, Automata, Syntensor, Peptone and Cradle and is a Scientific Advisory Board member at Danaher, Inc.